Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Alberta

$17,500.00

Engineering Adipocytes for Light-Controlled Secretion of Bioactive Insulin

FY 2014-15

Summary
Type 1 diabetes, a disease affecting approximately 300,000 Canadians, is caused by the loss of insulin production and secretion, thereby resulting in poorly regulated blood sugar levels. Established and new therapies are limited by inconvenience/discomfort (daily insulin injections) or long-term ineffectiveness, donor scarcity, and the need for potentially toxic immunosuppressive drugs (islet transplantation). Thus, using patients' own cells, such as abundant and easily accessible adipocytes (fat cells), would eradicate the need for immunosuppressants and the issue of scarcity. Furthermore, it has been shown that adipocytes can be genetically modified to produce and secrete insulin, although in an unregulated manner. In this project, we propose the use of optogenetics, or light stimulation, to cause regulated secretion of insulin from genetically modified adipocytes. Based on preliminary results, we believe that engineered fat cells and tissue will be able to secrete self-produced insulin when stimulated with blue light. As such, transplanting animals with this engineered tissue should provide effective and tightly controlled blood sugar regulation upon blue light stimulation. This novel concept could potentially lead to a non-invasive, needle-free type 1 diabetes treatment approach that is devoid of the major drawbacks of current therapies.
Program
Master's Award: Canada Graduate Scholarships
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
331335
Name
Ondrusova Katarina
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Engineering Adipocytes for Light-Controlled Secretion of Bioactive Insulin
Programtype2
Studentship Programs
Orgnameinp2
University of Alberta
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Adipocytes; Blood Glucose Regulation; Blue Light; Channelrhodopsins; Optogenetics; Type 1 Diabetes Mellitus
Abstract
Type 1 diabetes, a disease affecting approximately 300,000 Canadians, is caused by the loss of insulin production and secretion, thereby resulting in poorly regulated blood sugar levels. Established and new therapies are limited by inconvenience/discomfort (daily insulin injections) or long-term ineffectiveness, donor scarcity, and the need for potentially toxic immunosuppressive drugs (islet transplantation). Thus, using patients' own cells, such as abundant and easily accessible adipocytes (fat cells), would eradicate the need for immunosuppressants and the issue of scarcity. Furthermore, it has been shown that adipocytes can be genetically modified to produce and secrete insulin, although in an unregulated manner. In this project, we propose the use of optogenetics, or light stimulation, to cause regulated secretion of insulin from genetically modified adipocytes. Based on preliminary results, we believe that engineered fat cells and tissue will be able to secrete self-produced insulin when stimulated with blue light. As such, transplanting animals with this engineered tissue should provide effective and tightly controlled blood sugar regulation upon blue light stimulation. This novel concept could potentially lead to a non-invasive, needle-free type 1 diabetes treatment approach that is devoid of the major drawbacks of current therapies.
Competitiondate
201412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Ondrusova, Katarina
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~